161 related articles for article (PubMed ID: 33000273)
21. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
[TBL] [Abstract][Full Text] [Related]
22. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 May; 36(5):3583-9. PubMed ID: 25560487
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
Zhang Y; Yang X; Wu H; Zhou W; Liu Z
Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532
[TBL] [Abstract][Full Text] [Related]
24. N-Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM8.
Li M; Fang L; Kwantwi LB; He G; Luo W; Yang L; Huang Y; Yin S; Cai Y; Ma W; Zhan H; Tong Z; Zhang L; Liang C; Yin Y
Med Oncol; 2021 Sep; 38(10):127. PubMed ID: 34523032
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
[TBL] [Abstract][Full Text] [Related]
26. Downregulated Krüppel‑like factor 4 expression is associated with the aggressiveness of prostate cancer.
Zhang N; Su P; Li X; Xi J; Li X; Xu L
Oncol Rep; 2019 Mar; 41(3):1789-1796. PubMed ID: 30747213
[TBL] [Abstract][Full Text] [Related]
27. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression.
Xue M; Zhao L; Yang F; Li Z; Li G
Mol Med Rep; 2016 Jan; 13(1):1033-9. PubMed ID: 26647829
[TBL] [Abstract][Full Text] [Related]
29. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
31. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
32. A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.
Chang C; Liu J; He W; Qu M; Huang X; Deng Y; Shen L; Zhao X; Guo H; Jiang J; Fu XY; Huang R; Zhang D; Yan J
Oncogene; 2018 Jan; 37(4):415-426. PubMed ID: 28967902
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
Guo Z; He C; Yang F; Qin L; Lu X; Wu J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
[TBL] [Abstract][Full Text] [Related]
36. The role of HOXC6 in prostate cancer development.
Hamid AR; Hoogland AM; Smit F; Jannink S; van Rijt-van de Westerlo C; Jansen CF; van Leenders GJ; Verhaegh GW; Schalken JA
Prostate; 2015 Dec; 75(16):1868-76. PubMed ID: 26310814
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
38. Effects of zinc finger protein 403 on the proliferation, migration and invasion abilities of prostate cancer cells.
Xu X; Zhu Z; Xu Y; Tian S; Jiang Y; Zhao H
Oncol Rep; 2020 Dec; 44(6):2455-2464. PubMed ID: 33125130
[TBL] [Abstract][Full Text] [Related]
39. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.
Wang CQ; Tang CH; Wang Y; Jin L; Wang Q; Li X; Hu GN; Huang BF; Zhao YM; Su CM
Sci Rep; 2017 Nov; 7(1):15887. PubMed ID: 29162880
[TBL] [Abstract][Full Text] [Related]
40. Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer.
Qiu J; Peng S; Si-Tu J; Hu C; Huang W; Mao Y; Qiu W; Li K; Wang D
BMC Cancer; 2017 May; 17(1):360. PubMed ID: 28532481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]